z-logo
open-access-imgOpen Access
Edoxaban Use in Nonvalvular Atrial Fibrillation With Valvular Heart Disease—Insights from ENGAGE AF‐TIMI 48
Author(s) -
Owens Ryan E.,
Kabra Rajesh,
Oliphant Carrie S.
Publication year - 2017
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.22690
Subject(s) - medicine , edoxaban , atrial fibrillation , cardiology , valvular heart disease , rivaroxaban , dabigatran , apixaban , mitral regurgitation , population , stenosis , warfarin , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom